Management of Post-TOF Repair Using Transannular Patching
All patients who have undergone TOF repair with a transannular patch must have at least annual follow-up with a cardiologist who has expertise in adult congenital heart disease (ACHD), with comprehensive echocardiographic and/or MRI imaging performed by staff with ACHD expertise. 1
Key Postoperative Surveillance Issues
The transannular patch repair, while effective for relieving right ventricular outflow tract obstruction, creates an almost inevitable consequence: significant pulmonary regurgitation (PR) is encountered in virtually all patients following transannular patch repair 2. This is the most common and critical problem you'll face in long-term management, though it's frequently missed on clinical examination because the murmur is short and quiet 3.
Priority Monitoring Parameters
Your surveillance strategy should systematically evaluate for these complications, listed in order of clinical importance:
Hemodynamic Issues:
- Pulmonary regurgitation - The dominant problem; severe chronic PR eventually leads to symptomatic RV dilation and dysfunction 2
- RV dilation and dysfunction - Due to chronic PR, possibly with associated tricuspid regurgitation (TR creates a vicious cycle of more RV dilation) 1
- Residual RVOT obstruction - Can occur at infundibulum, valve level, or branch pulmonary arteries 2
- Branch pulmonary artery stenosis or hypoplasia 1
- Progressive aortic regurgitation - Seen in 15% of adults late after repair, related to intrinsic aortic abnormalities and increased flow 2
- Residual VSD - From patch dehiscence or incomplete closure 2
Arrhythmic Complications:
- Sustained ventricular tachycardia - Related to progressive hemodynamic problems and surgical scarring 1
- Sudden cardiac death - Reported in 1-6% of cases, mostly from VT/VF, accounting for one-third to half of late deaths 2
- AV block, atrial flutter, and/or atrial fibrillation 1
Diagnostic Workup Algorithm
1. Annual Clinical Assessment
- Examine specifically for: cardiomegaly on chest x-ray (prompts search for residual hemodynamic lesion, commonly PR), development of any arrhythmias (prompts search for underlying hemodynamic abnormality), hypoxemia (search for PFO/ASD with right-to-left shunt), RV enlargement or dysfunction with TR 3
2. Imaging Studies
Echocardiography (Class I recommendation): Comprehensive echocardiographic imaging should be performed in a regional ACHD center to evaluate 1:
- Severity of residual RVOT obstruction and PR
- Presence and severity of TR
- Tricuspid regurgitant velocity for RV pressure measurement
- Residual VSD
- RV size and function (qualitatively)
- Aortic root dilation and AR
MRI (Class I recommendation): MRI is the reference standard for 1:
- RV volume and systolic function quantification
- Severity of pulmonary regurgitation
- Pulmonary artery anatomy
- Ascending aorta evaluation
- Left-sided heart disease assessment
3. Exercise Testing
Use to objectively assess functional capacity and evaluate possible exertional arrhythmias; serial evaluations are helpful 3
4. Genetic Screening
Screen all patients for 22q11 deletion (Class I recommendation) - approximately 15% of TOF patients have this deletion with subsequent autosomal dominant inheritance and frequent early onset of depression or psychiatric disease 2, 1
Medical Management
Most patients need no regular medication in the absence of significant residual hemodynamic abnormality. Heart failure medications may be necessary in the setting of RV and LV dysfunction 3.
Indications for Reintervention
Class I Indications for Pulmonary Valve Replacement:
- Severe PR with symptoms or decreased exercise tolerance 3
Class IIa Indications for Pulmonary Valve Replacement:
Severe PR with any of the following 3:
- Moderate to severe RV dysfunction
- Moderate to severe RV enlargement
- Development of symptomatic or sustained atrial and/or ventricular arrhythmias
- Moderate to severe TR
Class IIa Indications for Surgery (Other Lesions):
Residual RVOT obstruction with 3:
- Peak instantaneous echo gradient >50 mmHg
- RV/LV pressure ratio >0.7
- Progressive and/or severe RV dilatation with dysfunction
Other indications 3:
- Residual VSD with left-to-right shunt >1.5:1
- Severe AR with symptoms or more than mild LV dysfunction
- Combination of multiple residual lesions leading to RV enlargement or reduced function
Critical Pitfalls to Avoid
Missing pulmonary regurgitation on clinical exam - The murmur is characteristically short and quiet; don't rely on auscultation alone 3
Delaying intervention until RV dysfunction is irreversible - Similar to aortic regurgitation, waiting until RV function deteriorates may be too late 4
Overlooking coronary anatomy before reintervention - Always ascertain coronary artery anatomy, specifically the possibility of an anomalous anterior descending coronary artery across the RVOT before operative intervention (Class I recommendation) 3
Ignoring arrhythmias as isolated events - Development of arrhythmias (atrial or ventricular) should prompt search for underlying hemodynamic abnormality, commonly PR 3
Missing syndromal associations - Before pregnancy or if genetic syndrome identified, arrange consultation with geneticist (Class I recommendation) 1
Long-Term Outcomes Context
Late survival after tetralogy repair is excellent, with 35-year survival of approximately 85% 2, 3, 2. However, transannular patch repair is associated with significantly higher rates of reintervention compared to annulus-sparing techniques - studies show cumulative incidence of pulmonary valve replacement of 58.9% at 20 years for TAP versus 40.2% for annulus-sparing repair 5. The need for reintervention, usually for pulmonary valve insertion, increases after the second decade of life 3.
Pregnancy Considerations
Before pregnancy, consultation with a geneticist should be arranged (Class I recommendation) 1. Most patients tolerate pregnancy well if there are no significant residual hemodynamic lesions, but this requires careful pre-pregnancy assessment.